Mesoblast’s (MESO) “Overweight” Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Mesoblast (NASDAQ:MESO – Free Report) in a report published on Tuesday, Benzinga reports. Separately, StockNews.com downgraded Mesoblast from a hold rating to a sell rating in a research note on Wednesday, May 8th. Two investment analysts have rated the stock with a sell rating, three have […]
More Stories
Direxion Daily Small Cap Bull 3X Shares (NYSEARCA:TNA) Sets New 12-Month High – Still a Buy?
Direxion Daily Small Cap Bull 3X Shares (NYSEARCA:TNA – Get Free Report)’s share price hit a new 52-week high during...
Brookfield Business Partners (TSE:BBU.UN) Reaches New 1-Year High – Here’s What Happened
Shares of Brookfield Business Partners LP (TSE:BBU.UN – Get Free Report) reached a new 52-week high during mid-day trading on...
OneSpaWorld (NASDAQ:OSW) Hits New 12-Month High – Time to Buy?
OneSpaWorld Holdings Limited (NASDAQ:OSW – Get Free Report)’s share price hit a new 52-week high during trading on Monday ....
Semler Scientific (NASDAQ:SMLR) Shares Gap Up – Should You Buy?
Semler Scientific, Inc. (NASDAQ:SMLR – Get Free Report) shares gapped up before the market opened on Monday . The stock...
Semtech (NASDAQ:SMTC) Releases Q4 2025 Earnings Guidance
Semtech (NASDAQ:SMTC – Get Free Report) updated its fourth quarter 2025 earnings guidance on Monday. The company provided EPS guidance...
PayPal (NASDAQ:PYPL) Stock Price Up 1.6% – Time to Buy?
PayPal Holdings, Inc. (NASDAQ:PYPL – Get Free Report) shares rose 1.6% on Monday . The company traded as high as...